Marketing Analysis Ranbaxy Laboratories - 1306 Words

1. Industry Analysis: By 2020, India is likely to be among the top three pharmaceutical markets by incremental growth and sixth largest market globally in absolute size The Indian pharmaceuticals market increased at a CAGR of 12.79 per cent in 2015 from US$ 6 billion in 2005, and is expected to expand at a CAGR of 15.92 per cent to US$ 55 billion by 2020 Over 2012–20, total healthcare spending is expected to rise at a CAGR of 20 per cent to US$ 280 billion from US$ 65 billion Pharmaceutical sales, as a percentage of total healthcare spending, are expected to increase to 27 per cent by 2016 from 18.9 per cent in 2008 2. Company Profile 1.1. Ranbaxy Laboratories 2.1.1. Business Overview †¢ Ranbaxy Laboratories Limited (BSE: 500359) is an Indian multinational pharmaceutical company that was incorporated in India in 1961 and went public in 1973. It is an integrated, research based, international pharmaceutical company, producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. †¢ The Company has a global footprint in 43 countries, world-class manufacturing facilities in 8 countries and serves customers in over 125 countries. †¢ In June 2008, Ranbaxy entered into an alliance with one of the largest Japanese innovator companies, Daiichi Sankyo Company Ltd., to create an innovator and generic pharmaceutical powerhouse. The combined entity now ranks among the top 20 pharmaceutical companies, globally. †¢Show MoreRelatedEli Lilly in India3134 Words   |  13 PagesEli Lilly in India: Rethinking the Joint Venture Strategy Case Study Analysis – Final Exam Submitted by Lloyd Stallings April 15, 2012 IMAN 615: Dr. Daniel E. Gilbert Eli Lilly in India: Rethinking the Joint Venture Strategy Executive Summary Eli Lilly and Company is a pharmaceutical company, founded in 1876, that integrates many departments and supply-chain management.    The company in itself discovers, develops, manufacturesRead MoreEli Lilly Ranbaxy joint venture Essay1488 Words   |  6 Pagesï » ¿Executive Summary The Eli Lilly Ranbaxy joint venture allowed both Eli Lilly and Ranbaxy as separate companies to grow and expand as one venture. The support and reliability that both companies had with one another allowed for a strong business relationship to form which led to the same business strategy vision and goals. This joint venture eliminated trade with other companies for the same thing that one another could share to become one of the largest and most successful pharmaceutical companiesRead MoreEli Lilly Case3863 Words   |  16 Pagessince early 80’s and it was not until 1993 that Eli Lilly International decided to establish a Joint Venture with India’s second largest laboratory and exporter, Ranbaxy. This move happened in a very challenging context as both companies have very different profiles and backgrounds. The main differential characteristic was the nature of their products. While Ranbaxy was focused on generics and in other intermediate products, Eli Lilly Internat ional core business was the commercialization and developmentRead MoreEli Lilly Case3871 Words   |  16 Pagessince early 80’s and it was not until 1993 that Eli Lilly International decided to establish a Joint Venture with India’s second largest laboratory and exporter, Ranbaxy. This move happened in a very challenging context as both companies have very different profiles and backgrounds. The main differential characteristic was the nature of their products. While Ranbaxy was focused on generics and in other intermediate products, Eli Lilly International core business was the commercialization and developmentRead MoreSWOT Analysis of Indian Pharma Industry2434 Words   |  10 PagesSWOT Analysis of Pharmaceutical Sector in India: Strengths: 1. Indian with a population of over a billion is a largely untapped market. In fact the penetration of modern medicine is less than 30% in India. 2. The growth of middle class in the country has resulted in fast changing lifestyles in urban and to some extent rural centers. 3. Indian manufacturers are one of the lowest cost producers of drugs in the world. With a scalable labor force, Indian manufactures can produce drugs at 40% to 50% ofRead MoreCorporate Social Responsibility in Ranbaxy Laboratories10038 Words   |  41 Pages| Corporate Social Responsibility Report: RANBAXY LABORATORIES LTD | | ABSTRACT This report explores the Millennium Development Goals related to Healthcare at global and national level. It also focuses on the diseases that are prevalent in India and the steps taken by Ranbaxy towards the eradication of these diseases. It reviews the activities of Ranbaxy Laboratories towards the welfare of community and the protection of environment. It also throws light on the efforts done by the company inRead MoreSwot Analysis in Pharmaceutical Industry5127 Words   |  21 Pagestime. A SWOT Analysis looks at the strengths, weaknesses, opportunities and threats that are relevant to an organization in a new venture. A SWOT Analysis is a tool which allows users to look at the direction a company or organization may wish to move towards in the future. A SWOT Analysis is a useful tool, which in conjunction with others can help make informed decisions. Definition of SWOT Many people see SWOT as synonymous with strategic planning. In fact, a SWOT analysis is only one ofRead MoreFundamental Analysis of Pharmaceutical Stocks12364 Words   |  50 Pages------------------------------------------------- Fundamental Analysis Fundamental analysis is a technique that attempts to determine a security’s value by focusing on underlying factors that affect a company s actual business and its future prospects. On a broader scope, you can perform fundamental analysis on industries or the economy as a whole. The term simply refers to the analysis of the economic well-being of a financial entity as opposed to only its price movements. Fundamental analysis serves to answer questions, suchRead MoreImpact of Lipitor Patent Expiry on Pfizer.4174 Words   |  17 Pagesas it is the best marketing pharmaceutical company in the world it is using strategies to keep the sales up and to make the consumers keep using Lipitor even after the expiration. It is good news for the consumers but not so much for the pharmaceutical industry. Lipitor is a blockbuster drug which going generic is a very big deal in the world of pharmaceuticals; it has been responsible for making a 27% of total sales revenue for all biopharmaceuticals. Pfizer is the best marketing pharmaceutical companyRead MoreHistory of Indian Pharma Industry11902 Words   |  48 Pages Top 10 Pharmaceutical Companies in India |Rank |Company Name |Turnover Amount |Remarks | |1. |Ranbaxy |4198.96 | | |2. |Dr. Reddy Lab. |4162.25 | | |3.